0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Subcutaneous Drug Delivery Devices Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-0D10212
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Subcutaneous Drug Delivery Devices Market Insights Forecast to 2028
BUY CHAPTERS

Global Subcutaneous Drug Delivery Devices Market Research Report 2025

Code: QYRE-Auto-0D10212
Report
August 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Subcutaneous Drug Delivery Devices Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Subcutaneous Drug Delivery Devices Market

Subcutaneous Drug Delivery Devices Market

The global market for Subcutaneous Drug Delivery Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A subcutaneous drug delivery device having a housing having an internal reservoir in communication with a drug delivery needle via a fluid path. An expandable chamber disposed adjacent to the reservoir forces drug from the reservoir to the needle when supplied with a gas.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Subcutaneous Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Drug Delivery Devices.
The Subcutaneous Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Subcutaneous Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Drug Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Subcutaneous Drug Delivery Devices Market Report

Report Metric Details
Report Name Subcutaneous Drug Delivery Devices Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BD, Insulet Corporation, Enable Injections, West Pharmaceutical Services, Inc, Ypsomed AG, Elcam Medical, Amgen, Wilhelm Haselmeier
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Subcutaneous Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Subcutaneous Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Subcutaneous Drug Delivery Devices Market report?

Ans: The main players in the Subcutaneous Drug Delivery Devices Market are BD, Insulet Corporation, Enable Injections, West Pharmaceutical Services, Inc, Ypsomed AG, Elcam Medical, Amgen, Wilhelm Haselmeier

What are the Application segmentation covered in the Subcutaneous Drug Delivery Devices Market report?

Ans: The Applications covered in the Subcutaneous Drug Delivery Devices Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Subcutaneous Drug Delivery Devices Market report?

Ans: The Types covered in the Subcutaneous Drug Delivery Devices Market report are Prefilled Injectable, Filled Injectable

Recommended Reports

Drug Delivery Devices

Drug Delivery Technologies

Therapy & Treatment Devices

1 Subcutaneous Drug Delivery Devices Market Overview
1.1 Product Definition
1.2 Subcutaneous Drug Delivery Devices by Type
1.2.1 Global Subcutaneous Drug Delivery Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 Prefilled Injectable
1.2.3 Filled Injectable
1.3 Subcutaneous Drug Delivery Devices by Application
1.3.1 Global Subcutaneous Drug Delivery Devices Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Subcutaneous Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Subcutaneous Drug Delivery Devices Revenue 2020-2031
1.4.2 Global Subcutaneous Drug Delivery Devices Sales 2020-2031
1.4.3 Global Subcutaneous Drug Delivery Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Subcutaneous Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Subcutaneous Drug Delivery Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global Subcutaneous Drug Delivery Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Subcutaneous Drug Delivery Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Subcutaneous Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Subcutaneous Drug Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Subcutaneous Drug Delivery Devices, Product Type & Application
2.7 Global Key Manufacturers of Subcutaneous Drug Delivery Devices, Date of Enter into This Industry
2.8 Global Subcutaneous Drug Delivery Devices Market Competitive Situation and Trends
2.8.1 Global Subcutaneous Drug Delivery Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Subcutaneous Drug Delivery Devices Players Market Share by Revenue
2.8.3 Global Subcutaneous Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Subcutaneous Drug Delivery Devices Market Scenario by Region
3.1 Global Subcutaneous Drug Delivery Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Subcutaneous Drug Delivery Devices Sales by Region: 2020-2031
3.2.1 Global Subcutaneous Drug Delivery Devices Sales by Region: 2020-2025
3.2.2 Global Subcutaneous Drug Delivery Devices Sales by Region: 2026-2031
3.3 Global Subcutaneous Drug Delivery Devices Revenue by Region: 2020-2031
3.3.1 Global Subcutaneous Drug Delivery Devices Revenue by Region: 2020-2025
3.3.2 Global Subcutaneous Drug Delivery Devices Revenue by Region: 2026-2031
3.4 North America Subcutaneous Drug Delivery Devices Market Facts & Figures by Country
3.4.1 North America Subcutaneous Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Subcutaneous Drug Delivery Devices Sales by Country (2020-2031)
3.4.3 North America Subcutaneous Drug Delivery Devices Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Subcutaneous Drug Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Subcutaneous Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Subcutaneous Drug Delivery Devices Sales by Country (2020-2031)
3.5.3 Europe Subcutaneous Drug Delivery Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Subcutaneous Drug Delivery Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Subcutaneous Drug Delivery Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Subcutaneous Drug Delivery Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Subcutaneous Drug Delivery Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Subcutaneous Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Subcutaneous Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Subcutaneous Drug Delivery Devices Sales by Country (2020-2031)
3.7.3 Latin America Subcutaneous Drug Delivery Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Subcutaneous Drug Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Subcutaneous Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Subcutaneous Drug Delivery Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Subcutaneous Drug Delivery Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Subcutaneous Drug Delivery Devices Sales by Type (2020-2031)
4.1.1 Global Subcutaneous Drug Delivery Devices Sales by Type (2020-2025)
4.1.2 Global Subcutaneous Drug Delivery Devices Sales by Type (2026-2031)
4.1.3 Global Subcutaneous Drug Delivery Devices Sales Market Share by Type (2020-2031)
4.2 Global Subcutaneous Drug Delivery Devices Revenue by Type (2020-2031)
4.2.1 Global Subcutaneous Drug Delivery Devices Revenue by Type (2020-2025)
4.2.2 Global Subcutaneous Drug Delivery Devices Revenue by Type (2026-2031)
4.2.3 Global Subcutaneous Drug Delivery Devices Revenue Market Share by Type (2020-2031)
4.3 Global Subcutaneous Drug Delivery Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Subcutaneous Drug Delivery Devices Sales by Application (2020-2031)
5.1.1 Global Subcutaneous Drug Delivery Devices Sales by Application (2020-2025)
5.1.2 Global Subcutaneous Drug Delivery Devices Sales by Application (2026-2031)
5.1.3 Global Subcutaneous Drug Delivery Devices Sales Market Share by Application (2020-2031)
5.2 Global Subcutaneous Drug Delivery Devices Revenue by Application (2020-2031)
5.2.1 Global Subcutaneous Drug Delivery Devices Revenue by Application (2020-2025)
5.2.2 Global Subcutaneous Drug Delivery Devices Revenue by Application (2026-2031)
5.2.3 Global Subcutaneous Drug Delivery Devices Revenue Market Share by Application (2020-2031)
5.3 Global Subcutaneous Drug Delivery Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Company Information
6.1.2 BD Description and Business Overview
6.1.3 BD Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BD Subcutaneous Drug Delivery Devices Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Insulet Corporation
6.2.1 Insulet Corporation Company Information
6.2.2 Insulet Corporation Description and Business Overview
6.2.3 Insulet Corporation Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Insulet Corporation Subcutaneous Drug Delivery Devices Product Portfolio
6.2.5 Insulet Corporation Recent Developments/Updates
6.3 Enable Injections
6.3.1 Enable Injections Company Information
6.3.2 Enable Injections Description and Business Overview
6.3.3 Enable Injections Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Enable Injections Subcutaneous Drug Delivery Devices Product Portfolio
6.3.5 Enable Injections Recent Developments/Updates
6.4 West Pharmaceutical Services, Inc
6.4.1 West Pharmaceutical Services, Inc Company Information
6.4.2 West Pharmaceutical Services, Inc Description and Business Overview
6.4.3 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Product Portfolio
6.4.5 West Pharmaceutical Services, Inc Recent Developments/Updates
6.5 Ypsomed AG
6.5.1 Ypsomed AG Company Information
6.5.2 Ypsomed AG Description and Business Overview
6.5.3 Ypsomed AG Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ypsomed AG Subcutaneous Drug Delivery Devices Product Portfolio
6.5.5 Ypsomed AG Recent Developments/Updates
6.6 Elcam Medical
6.6.1 Elcam Medical Company Information
6.6.2 Elcam Medical Description and Business Overview
6.6.3 Elcam Medical Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Elcam Medical Subcutaneous Drug Delivery Devices Product Portfolio
6.6.5 Elcam Medical Recent Developments/Updates
6.7 Amgen
6.7.1 Amgen Company Information
6.7.2 Amgen Description and Business Overview
6.7.3 Amgen Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Amgen Subcutaneous Drug Delivery Devices Product Portfolio
6.7.5 Amgen Recent Developments/Updates
6.8 Wilhelm Haselmeier
6.8.1 Wilhelm Haselmeier Company Information
6.8.2 Wilhelm Haselmeier Description and Business Overview
6.8.3 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Product Portfolio
6.8.5 Wilhelm Haselmeier Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Subcutaneous Drug Delivery Devices Industry Chain Analysis
7.2 Subcutaneous Drug Delivery Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Subcutaneous Drug Delivery Devices Production Mode & Process Analysis
7.4 Subcutaneous Drug Delivery Devices Sales and Marketing
7.4.1 Subcutaneous Drug Delivery Devices Sales Channels
7.4.2 Subcutaneous Drug Delivery Devices Distributors
7.5 Subcutaneous Drug Delivery Devices Customer Analysis
8 Subcutaneous Drug Delivery Devices Market Dynamics
8.1 Subcutaneous Drug Delivery Devices Industry Trends
8.2 Subcutaneous Drug Delivery Devices Market Drivers
8.3 Subcutaneous Drug Delivery Devices Market Challenges
8.4 Subcutaneous Drug Delivery Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Subcutaneous Drug Delivery Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Subcutaneous Drug Delivery Devices Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Subcutaneous Drug Delivery Devices Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Subcutaneous Drug Delivery Devices Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Subcutaneous Drug Delivery Devices Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Subcutaneous Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Subcutaneous Drug Delivery Devices Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Subcutaneous Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Subcutaneous Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Subcutaneous Drug Delivery Devices, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Subcutaneous Drug Delivery Devices, Product Type & Application
 Table 12. Global Key Manufacturers of Subcutaneous Drug Delivery Devices, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Subcutaneous Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Drug Delivery Devices as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Subcutaneous Drug Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Subcutaneous Drug Delivery Devices Sales by Region (2020-2025) & (K Units)
 Table 18. Global Subcutaneous Drug Delivery Devices Sales Market Share by Region (2020-2025)
 Table 19. Global Subcutaneous Drug Delivery Devices Sales by Region (2026-2031) & (K Units)
 Table 20. Global Subcutaneous Drug Delivery Devices Sales Market Share by Region (2026-2031)
 Table 21. Global Subcutaneous Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Region (2020-2025)
 Table 23. Global Subcutaneous Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Region (2026-2031)
 Table 25. North America Subcutaneous Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Subcutaneous Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 27. North America Subcutaneous Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 28. North America Subcutaneous Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Subcutaneous Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Subcutaneous Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Subcutaneous Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Subcutaneous Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Subcutaneous Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Subcutaneous Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Subcutaneous Drug Delivery Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Subcutaneous Drug Delivery Devices Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Subcutaneous Drug Delivery Devices Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Subcutaneous Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Subcutaneous Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Subcutaneous Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Subcutaneous Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Subcutaneous Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Subcutaneous Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Subcutaneous Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Subcutaneous Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Subcutaneous Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Subcutaneous Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Subcutaneous Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Subcutaneous Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Subcutaneous Drug Delivery Devices Sales (K Units) by Type (2020-2025)
 Table 51. Global Subcutaneous Drug Delivery Devices Sales (K Units) by Type (2026-2031)
 Table 52. Global Subcutaneous Drug Delivery Devices Sales Market Share by Type (2020-2025)
 Table 53. Global Subcutaneous Drug Delivery Devices Sales Market Share by Type (2026-2031)
 Table 54. Global Subcutaneous Drug Delivery Devices Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Subcutaneous Drug Delivery Devices Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Type (2020-2025)
 Table 57. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Type (2026-2031)
 Table 58. Global Subcutaneous Drug Delivery Devices Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Subcutaneous Drug Delivery Devices Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Subcutaneous Drug Delivery Devices Sales (K Units) by Application (2020-2025)
 Table 61. Global Subcutaneous Drug Delivery Devices Sales (K Units) by Application (2026-2031)
 Table 62. Global Subcutaneous Drug Delivery Devices Sales Market Share by Application (2020-2025)
 Table 63. Global Subcutaneous Drug Delivery Devices Sales Market Share by Application (2026-2031)
 Table 64. Global Subcutaneous Drug Delivery Devices Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Subcutaneous Drug Delivery Devices Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Application (2020-2025)
 Table 67. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Application (2026-2031)
 Table 68. Global Subcutaneous Drug Delivery Devices Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Subcutaneous Drug Delivery Devices Price (USD/Unit) by Application (2026-2031)
 Table 70. BD Company Information
 Table 71. BD Description and Business Overview
 Table 72. BD Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. BD Subcutaneous Drug Delivery Devices Product
 Table 74. BD Recent Developments/Updates
 Table 75. Insulet Corporation Company Information
 Table 76. Insulet Corporation Description and Business Overview
 Table 77. Insulet Corporation Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Insulet Corporation Subcutaneous Drug Delivery Devices Product
 Table 79. Insulet Corporation Recent Developments/Updates
 Table 80. Enable Injections Company Information
 Table 81. Enable Injections Description and Business Overview
 Table 82. Enable Injections Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Enable Injections Subcutaneous Drug Delivery Devices Product
 Table 84. Enable Injections Recent Developments/Updates
 Table 85. West Pharmaceutical Services, Inc Company Information
 Table 86. West Pharmaceutical Services, Inc Description and Business Overview
 Table 87. West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Product
 Table 89. West Pharmaceutical Services, Inc Recent Developments/Updates
 Table 90. Ypsomed AG Company Information
 Table 91. Ypsomed AG Description and Business Overview
 Table 92. Ypsomed AG Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Ypsomed AG Subcutaneous Drug Delivery Devices Product
 Table 94. Ypsomed AG Recent Developments/Updates
 Table 95. Elcam Medical Company Information
 Table 96. Elcam Medical Description and Business Overview
 Table 97. Elcam Medical Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Elcam Medical Subcutaneous Drug Delivery Devices Product
 Table 99. Elcam Medical Recent Developments/Updates
 Table 100. Amgen Company Information
 Table 101. Amgen Description and Business Overview
 Table 102. Amgen Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Amgen Subcutaneous Drug Delivery Devices Product
 Table 104. Amgen Recent Developments/Updates
 Table 105. Wilhelm Haselmeier Company Information
 Table 106. Wilhelm Haselmeier Description and Business Overview
 Table 107. Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Product
 Table 109. Wilhelm Haselmeier Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Subcutaneous Drug Delivery Devices Distributors List
 Table 113. Subcutaneous Drug Delivery Devices Customers List
 Table 114. Subcutaneous Drug Delivery Devices Market Trends
 Table 115. Subcutaneous Drug Delivery Devices Market Drivers
 Table 116. Subcutaneous Drug Delivery Devices Market Challenges
 Table 117. Subcutaneous Drug Delivery Devices Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Subcutaneous Drug Delivery Devices
 Figure 2. Global Subcutaneous Drug Delivery Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Subcutaneous Drug Delivery Devices Market Share by Type: 2024 & 2031
 Figure 4. Prefilled Injectable Product Picture
 Figure 5. Filled Injectable Product Picture
 Figure 6. Global Subcutaneous Drug Delivery Devices Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Subcutaneous Drug Delivery Devices Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Others
 Figure 11. Global Subcutaneous Drug Delivery Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Subcutaneous Drug Delivery Devices Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Subcutaneous Drug Delivery Devices Sales (2020-2031) & (K Units)
 Figure 14. Global Subcutaneous Drug Delivery Devices Average Price (USD/Unit) & (2020-2031)
 Figure 15. Subcutaneous Drug Delivery Devices Report Years Considered
 Figure 16. Subcutaneous Drug Delivery Devices Sales Share by Manufacturers in 2024
 Figure 17. Global Subcutaneous Drug Delivery Devices Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Subcutaneous Drug Delivery Devices Players: Market Share by Revenue in Subcutaneous Drug Delivery Devices in 2024
 Figure 19. Subcutaneous Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Subcutaneous Drug Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Subcutaneous Drug Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 22. North America Subcutaneous Drug Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Subcutaneous Drug Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 26. Europe Subcutaneous Drug Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Subcutaneous Drug Delivery Devices Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Subcutaneous Drug Delivery Devices Revenue Market Share by Region (2020-2031)
 Figure 34. China Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Subcutaneous Drug Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Subcutaneous Drug Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Subcutaneous Drug Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Subcutaneous Drug Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Subcutaneous Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Subcutaneous Drug Delivery Devices by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Subcutaneous Drug Delivery Devices by Type (2020-2031)
 Figure 56. Global Subcutaneous Drug Delivery Devices Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Subcutaneous Drug Delivery Devices by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Subcutaneous Drug Delivery Devices by Application (2020-2031)
 Figure 59. Global Subcutaneous Drug Delivery Devices Price (USD/Unit) by Application (2020-2031)
 Figure 60. Subcutaneous Drug Delivery Devices Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS